September 27, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Viewpoints: Pros And Cons Of Biogen’s Decision To Reevaluate Alzheimer’s Drug; Isn’t It Really Time To Criminally Prosecute Companies Behind Opioid Epidemic?Editorial writers express views on these health issues and others. from Kaiser Health News https://ift.tt/33ZoC1a … Read More
Judge’s $1.6B Ruling On Unpaid Subsidies Highlights Just How Much Trump Administration Could Have To Pony UpThe insurers' lawsuit against the federal government revolves around cost-sharing reduction subsidies that were intended to lower healthcare costs for certain people who bought coverage on the Affordable Care Act exchanges. W… Read More
Los Angeles Vape District A Black-Market GatewayA five-block section of downtown Los Angeles that used to be part of the city’s Toy District has become ground zero for the nation’s counterfeit cannabis trade. While a few remaining stores sell fidget spinners and stuffed an… Read More
Pharma Sells States On ‘Netflix Model’ To Wipe Out Hep C. But At What Price?When a long, black bus bearing the logo of drugmaker AbbVie rolls through Washington state next year, it will promote a new effort to eradicate hepatitis C infections. The state is paying for the marketing campaign as part of… Read More
First Edition: October 25, 2019Today's early morning highlights from the major news organizations. from Kaiser Health News https://ift.tt/32SkgsQ … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment